FTSE MIB
34.262,73 +322,98 (+0,95%) Dow Jones
38.085,80 -375,12 (-0,98%) Nasdaq
15.611,76 -100,99 (-0,64%) Nikkei 225
37.934,76 +306,28 (+0,81%) Petrolio
84,35 +0,78 (+0,93%) Bitcoin EUR
60.000,28 +312,09 (+0,52%)
United-Guardian, Inc. (UG)
| Chiusura precedente | 8,42 |
| Aperto | 8,20 |
| Denaro | 0,00 x 0 |
| Lettera | 0,00 x 0 |
| Min-Max giorno | 8,00 - 8,37 |
| Intervallo di 52 settimane | 5,79 - 10,23 |
| Volume | |
| Media Volume | 8.819 |
| Capitalizzazione | 38,471M |
| Beta (5 anni mensile) | 0,72 |
| Rapporto PE (ttm) | 14,95 |
| EPS (ttm) | 0,56 |
| Prossima data utili | 09 mag 2024 - 13 mag 2024 |
| Rendimento e dividendo (futuro) | 0,35 (4,18%) |
| Data ex dividendo | 09 feb 2024 |
| Stima target 1A | N/D |
- GlobeNewswire
United-Guardian Reports Second Quarter Financial Results
HAUPPAUGE, N.Y., Aug. 11, 2023 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the second quarter and first half of 2023. Sales for the six-month period ended June 30th decreased from $7,518,535 in 2022 to $5,220,623 in 2023. Net income decreased from $1,544,789 ($0.34 per share) to $1,217,175 ($0.26 per share). Second quarter sales decreased from $3,626,177 to $2,650,299, with net income decreasing from $633,324 ($0.14 per share) to $461,094 ($0.1
GlobeNewswireUnited-Guardian Announces Mid-Year Dividend
HAUPPAUGE, N.Y., July 14, 2023 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today that the company's Board of Directors, at its meeting on July 12, 2023, declared a cash dividend of $0.10 per share, to be paid on August 2, 2023, to all stockholders of record as of the close of business on July 26, 2023. This will be the 28th consecutive year that the company has paid a dividend. Donna Vigilante, President of United-Guardian, stated, “I am pleased to report that the company’s B
- GlobeNewswire
United-Guardian Appoints New President
HAUPPAUGE, N.Y., June 13, 2023 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ: UG), a manufacturer of cosmetic ingredients, pharmaceuticals, and medical products, announced today that the company’s Board of Directors has appointed Donna Vigilante as the company’s next President. Ms. Vigilante, 43, is currently one of the company’s vice presidents, and manages the company’s Research and Development department. She succeeds Beatriz Blanco, the company’s current President, who will be leaving th
